Pages that link to "Q48772738"

The following pages link to Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia (Q48772738):

Displaying 45 items.

• Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders (Q30470007) (← links)
• Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. (Q30532041) (← links)
• Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder (Q33628457) (← links)
• Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia (Q33691327) (← links)
• Cytokine and growth factor involvement in schizophrenia--support for the developmental model (Q34111013) (← links)
• The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia (Q34156147) (← links)
• Cholecystokinin: A multi‐functional molecular switch of neuronal circuits (Q34420892) (← links)
• Neuropeptides involved in the pathophysiology of schizophrenia and major depression (Q35130197) (← links)
• The diagnostic validity of paraphrenia. (Q36088750) (← links)
• Somatostatinergic systems: an update on brain functions in normal and pathological aging (Q36449496) (← links)
• The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions (Q36633604) (← links)
• Involvement of neuropeptide systems in schizophrenia: human studies (Q36756393) (← links)
• Animal and clinical research on neuropeptides and schizophrenia. (Q38177697) (← links)
• How do the neuropathological changes of schizophrenia relate to pre-existing neurotransmitter and aetiological hypotheses? (Q38365546) (← links)
• GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia (Q38523551) (← links)
• Neuropeptides, dopamine, and schizophrenia (Q39548116) (← links)
• Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems (Q39548142) (← links)
• Post-mortem neurochemistry of schizophrenia (Q39583555) (← links)
• Cholecystokinin and schizophrenia (Q39750053) (← links)
• A neural plasticity hypothesis of schizophrenia (Q40094167) (← links)
• Postmortem studies in psychiatry. (Q40188020) (← links)
• Chemical brain anatomy in schizophrenia (Q40473365) (← links)
• The relationship of negative schizophrenia to parkinsonism (Q41178359) (← links)
• Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics (Q41581740) (← links)
• Interactions of cholecystokinin and dopamine in the nucleus accumbens (Q41879525) (← links)
• Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls (Q42454881) (← links)
• Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation (Q43506806) (← links)
• Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study (Q45298042) (← links)
• Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of startle in the rat (Q46183690) (← links)
• Somatostatin-like immunoreactivity in CSF of schizophrenic patients during haloperidol treatment (Q46420911) (← links)
• Cholecystokinin-2 receptor mediated gene expression in neuronal PC12 cells (Q46889721) (← links)
• Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions (Q46905684) (← links)
• Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy (Q47737537) (← links)
• Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics (Q48223883) (← links)
• Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. (Q48245172) (← links)
• Enzyme immunoassay for cholecystokinin octapeptide sulfate and its application (Q48373268) (← links)
• Merck, Sharp & Dohme Prize for Young Psychopharmacologists: A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia (Q48400379) (← links)
• Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state? (Q48578177) (← links)
• The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum (Q48810392) (← links)
• Distribution of GABA and neuropeptides in the human cerebral cortex. A light and electron microscopic study (Q48821338) (← links)
• Possible association of a cholecystokinin promoter variant to schizophrenia. (Q51955321) (← links)
• The human amygdaloid complex: A cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining (Q52061414) (← links)
• Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies (Q52080972) (← links)
• Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration (Q69681016) (← links)
• Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disorders (Q82885628) (← links)